-
EP1317284
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1317284
| EP1317284 - ANTIBODY AND/OR CHEMOKINE CONSTRUCTS WHICH BIND TO A CHEMOKINE RECEPTOR AND THEIR USE IN IMMUNOLOGICAL DISORDERS [Right-click to bookmark this link] | Status | The application has been refused Status updated on 08.05.2009 Database last updated on 02.11.2024 | Most recent event Tooltip | 08.05.2009 | Refusal of application | published on 10.06.2009 [2009/24] | Applicant(s) | For all designated states Micromet AG Staffelseestrasse 2 81477 München / DE | [2003/24] | Inventor(s) | 01 /
MACK, Matthias Horemansstrasse 26a 80636 München / DE | 02 /
SCHLOENDORFF, Detlef Kaiserplatz 2 80803 München / DE | 03 /
SPRING, Michael Biberweg 2 82223 Eichenau / DE | [2003/24] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
| Former [2003/24] | VOSSIUS & PARTNER Siebertstrasse 4 81675 München / DE | Application number, filing date | 01980364.2 | 10.09.2001 | [2003/24] | WO2001EP10433 | Priority number, date | EP20000119694 | 08.09.2000 Original published format: EP 00119694 | US20010948004 | 05.09.2001 Original published format: US 948004 | [2003/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0220615 | Date: | 14.03.2002 | Language: | EN | [2002/11] | Type: | A2 Application without search report | No.: | EP1317284 | Date: | 11.06.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.03.2002 takes the place of the publication of the European patent application. | [2003/24] | Search report(s) | International search report - published on: | EP | 25.07.2002 | Classification | IPC: | A61K39/395, A61K38/19, A61K47/48, C12N15/12, C12N15/13, C12N15/62, C12N15/79, C07K16/28, C07K19/00, A61K31/7088, A61P17/00, A61P19/00, A61P31/18, A61P37/06 | [2003/24] | CPC: |
C07K16/2866 (EP);
A61P1/00 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/18 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
C07K14/523 (EP);
C07K16/2809 (EP);
A61K2039/505 (EP);
A61K38/00 (EP);
A61K48/00 (EP);
C07K2317/34 (EP);
C07K2317/77 (EP);
C07K2319/00 (EP)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/24] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | ANTIKÖRPER- UND/ODER CHEMOKINKONSTRUKTE DIE AN EINEN CHEMOKINREZEPTOR BINDEN UND DEREN VERWENDUNG IN IMMUNOLOGISCHEN ERKRANKUNGEN | [2003/24] | English: | ANTIBODY AND/OR CHEMOKINE CONSTRUCTS WHICH BIND TO A CHEMOKINE RECEPTOR AND THEIR USE IN IMMUNOLOGICAL DISORDERS | [2003/24] | French: | CONSTRUCTIONS D'ANTICORPS ET/OU DE CHIMIOKINE QUI SE LIE A UN RECEPTEUR CHIMIOKINE ET LEUR UTILISATION CONTRE DES TROUBLES IMMUNOLOGIQUES | [2003/24] | Entry into regional phase | 07.04.2003 | National basic fee paid | 07.04.2003 | Designation fee(s) paid | 07.04.2003 | Examination fee paid | Examination procedure | 06.03.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 07.04.2003 | Amendment by applicant (claims and/or description) | 07.04.2003 | Examination requested [2003/24] | 20.10.2005 | Despatch of a communication from the examining division (Time limit: M04) | 21.02.2006 | Reply to a communication from the examining division | 06.07.2006 | Despatch of a communication from the examining division (Time limit: M02) | 23.08.2006 | Reply to a communication from the examining division | 23.03.2007 | Despatch of a communication from the examining division (Time limit: M08) | 30.11.2007 | Reply to a communication from the examining division | 18.12.2008 | Date of oral proceedings | 26.01.2009 | Minutes of oral proceedings despatched | 28.01.2009 | Despatch of communication that the application is refused, reason: substantive examination [2009/24] | 07.02.2009 | Application refused, date of legal effect [2009/24] | Fees paid | Renewal fee | 30.09.2003 | Renewal fee patent year 03 | 30.09.2004 | Renewal fee patent year 04 | 30.09.2005 | Renewal fee patent year 05 | 29.09.2006 | Renewal fee patent year 06 | 28.09.2007 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.09.2008 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0004926 (OSPREY PHARMACEUTICALS LIMITED [CA], et al) [X] 1-6,17-24,28,50 * claim - *; | [PX]WO0053633 (MACK MATTHIAS [DE], et al) [PX] 4-13,16-40,42-46,50* the whole document *; | [X] - M. MACK ET AL., "Depletion of CCR5+ cells with bispecific antibodies and chemokine-toxins: A new strategy to treat inflammatory renal diseases.", KIDNEY & BLOOD PRESSURE RESEARCH, Basel, Switzerland, (2000), vol. 23, no. 3-5, page 242, XP001073509 [X] 4-13,16-40,42,45,50 * abstract 86 * | [X] - L. WU ET AL., "Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.", THE JOURNAL OF EXPERIMENTAL MEDICINE, Tokyo, Japan, (19971020), vol. 186, no. 8, pages 1373 - 1381, XP002060734 [X] 1-3,5,6 * abstract * DOI: http://dx.doi.org/10.1084/jem.186.8.1373 | [DA] - M. MACK ET AL., "Aminooxypentane-RANTES induces CCR5 internalization but inhibits recyling: a novel inhibitory mechanism of HIV infection.", THE JOURNAL OF EXPERIMENTAL MEDICINE, tokyo, japan, (19980420), vol. 187, no. 8, pages 1215 - 1224, XP000916445 [DA] 10 * abstract * * page 1216, column R, line 34 - line 42 * DOI: http://dx.doi.org/10.1084/jem.187.8.1215 | [DA] - M. MACK ET AL., "A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE U.S.A., Washington, DC, USA, (19950718), vol. 92, pages 7021 - 7025, XP000566333 [DA] 7-13 * abstract * * figure 1 * DOI: http://dx.doi.org/10.1073/pnas.92.15.7021 | [PX] - H. BRUHL ET AL., "Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV.", THE JOURNAL OF IMMUNOLOGY, Baltimore, MD, USA, (20010215), vol. 166, no. 4, pages 2420 - 2426, XP002197003 [PX] 1-13,16-50 * the whole document * |